Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Clausse

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Cellular and Molecular Biology|January 1, 1983
Conductimetric measurements for proteinsC Orley, B Clausse
Biomaterials|October 1, 1989
Increased cytotoxicity of nanoparticle-carried Adriamycin in vitro and potentiation by verapamil and amiodaroneC Kubiak, P Couvreur, L Manil, et al.
Cancer Detection and Prevention|January 1, 1988
Constitutive expression of HLA class II antigens on EBV positive malignant cells from nasopharyngeal carcinoma: possible involvement in T cell infiltrationP Busson, K Braham, B Clausse, et al.
La Nouvelle Presse Medicale|January 12, 1980
[Non-Hodgkin's malignant lymphoma: reliability of "typing" using cyto-enzymatic markers. Comparison with immunological markers (author's transl)]C Micheau, A Bernard, E Pujade, et al.
Biochemical and Biophysical Research Communications|August 31, 1992
Heterogeneity among human nasopharyngeal carcinoma cell lines for inflammatory cytokines mRNA expression levelsY Mahé, K Hirose, B Clausse, et al.
International Journal of Cancer|May 4, 1999
Evidence of LMP1-TRAF3 interactions in glycosphingolipid-rich complexes of lymphoblastoid and nasopharyngeal carcinoma cellsH Ardila-Osorio, B Clausse, Z Mishal, et al.
Virology|February 17, 1997
High concentration of the EBV latent membrane protein 1 in glycosphingolipid-rich complexes from both epithelial and lymphoid cellsB Clausse, K Fizazi, V Walczak, et al.
International Journal of Cancer|July 9, 1991
Detection of anti-Epstein-Barr-virus transactivator (ZEBRA) antibodies in sera from patients with nasopharyngeal carcinomaI Joab, J C Nicolas, G Schwaab, et al.
The American Journal of Pathology|May 5, 2001
In vivo elimination of acentric double minutes containing amplified MYCN from neuroblastoma tumor cells through the formation of micronucleiA Valent, J Bénard, B Clausse, et al.
International Journal of Cancer|October 15, 1988
Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomasP Busson, G Ganem, P Flores, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Cellular and Molecular Biology|January 1, 1983
Conductimetric measurements for proteinsC Orley, B Clausse
Biomaterials|October 1, 1989
Increased cytotoxicity of nanoparticle-carried Adriamycin in vitro and potentiation by verapamil and amiodaroneC Kubiak, P Couvreur, L Manil, et al.
Cancer Detection and Prevention|January 1, 1988
Constitutive expression of HLA class II antigens on EBV positive malignant cells from nasopharyngeal carcinoma: possible involvement in T cell infiltrationP Busson, K Braham, B Clausse, et al.
La Nouvelle Presse Medicale|January 12, 1980
[Non-Hodgkin's malignant lymphoma: reliability of "typing" using cyto-enzymatic markers. Comparison with immunological markers (author's transl)]C Micheau, A Bernard, E Pujade, et al.
Biochemical and Biophysical Research Communications|August 31, 1992
Heterogeneity among human nasopharyngeal carcinoma cell lines for inflammatory cytokines mRNA expression levelsY Mahé, K Hirose, B Clausse, et al.
International Journal of Cancer|May 4, 1999
Evidence of LMP1-TRAF3 interactions in glycosphingolipid-rich complexes of lymphoblastoid and nasopharyngeal carcinoma cellsH Ardila-Osorio, B Clausse, Z Mishal, et al.
Virology|February 17, 1997
High concentration of the EBV latent membrane protein 1 in glycosphingolipid-rich complexes from both epithelial and lymphoid cellsB Clausse, K Fizazi, V Walczak, et al.
International Journal of Cancer|July 9, 1991
Detection of anti-Epstein-Barr-virus transactivator (ZEBRA) antibodies in sera from patients with nasopharyngeal carcinomaI Joab, J C Nicolas, G Schwaab, et al.
The American Journal of Pathology|May 5, 2001
In vivo elimination of acentric double minutes containing amplified MYCN from neuroblastoma tumor cells through the formation of micronucleiA Valent, J Bénard, B Clausse, et al.
International Journal of Cancer|October 15, 1988
Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomasP Busson, G Ganem, P Flores, et al.
Pageof 2